Abstract

http://ssrn.com/abstract=1137248
 
 

Footnotes (168)



 


 



Statins and Adverse Cardiovascular Events in Moderate Risk Females: A Statistical and Legal Analysis with Implications for FDA Preemption Claims


Theodore Eisenberg


Cornell University - Law School

Martin T. Wells


Cornell University - School of Law

May 21, 2008

Cornell Legal Studies Research Paper No. 09-003

Abstract:     
This article presents: (1) meta analyses of studies of cardioprotection of women and men by statins, including Lipitor (atorvastatin), and (2) a legal analysis of advertising promoting Lipitor as preventing heart attacks. The meta analyses of primary prevention clinical trials show statistically significant benefits for men but not for women, and a statistically significant difference between men and women. The analyses do not support (1) statin use to reduce heart attacks in women based on extrapolation from men, or (2) approving or advertising statins as reducing heart attacks without qualification in a population that includes many women. The legal analysis raises the question whether Lipitor's advertisements, which omit that Lipitor's clinical trial found slight increased risk for women, is consistent with the Food, Drug, and Cosmetics Act and related Food and Drug Administration (FDA) regulations. The analysis suggests that FDA regulation should not preempt state law actions challenging advertising that is not supported by FDA-approved labeling. Our findings suggesting inadequate regulation of the world's best-selling drug also counsel against courts accepting the FDA's claimed preemption of state law causes of action relating to warnings and safety. Courts evaluating preemption claims should consider actual agency performance as well as theoretical institutional competence. Billions of health care dollars may be being wasted on statin use by women but the current regulatory regime does not create incentives to prevent such behavior.

Number of Pages in PDF File: 36

Keywords: preemption, statins, FDA

JEL Classification: I10, I18, K12, K13

working papers series


Download This Paper

Date posted: May 25, 2008  

Suggested Citation

Eisenberg, Theodore and Wells, Martin T., Statins and Adverse Cardiovascular Events in Moderate Risk Females: A Statistical and Legal Analysis with Implications for FDA Preemption Claims (May 21, 2008). Cornell Legal Studies Research Paper No. 09-003. Available at SSRN: http://ssrn.com/abstract=1137248 or http://dx.doi.org/10.2139/ssrn.1137248

Contact Information

Theodore Eisenberg (Contact Author)
Cornell University - Law School ( email )
524 College Ave
Myron Taylor Hall
Ithaca, NY 14853
United States
607-255-6477 (Phone)
607-255-7193 (Fax)
Martin T. Wells
Cornell University - School of Law ( email )
Comstock Hall
Ithaca, NY 14853
United States
607-255-8801 (Phone)
Feedback to SSRN


Paper statistics
Abstract Views: 1,707
Downloads: 167
Download Rank: 100,116
Footnotes:  168

© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright   Contact Us
This page was processed by apollo5 in 0.812 seconds